Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Autor: Wynn, Daniel, Kaufman, Michael, Montalban, Xavier, Vollmer, Timothy, Simon, Jack, Elkins, Jacob, O'Neill, Gilmore, Neyer, Lauri, Sheridan, James, Wang, Chungchi, Fong, Alice, Rose, John W
Zdroj: In Lancet Neurology 2010 9(4):381-390
Databáze: ScienceDirect